EUVIMEDEUVIMED entdecken
Crossref

Adipose Tissue-Derived Mesenchymal Stem Cells (AD-MSC) Versus Platelet-Rich Plasma (PRP) in the Arthroscopic Treatment of Chondral Defects of The Knee: What’s The Best? A Histological and Clinical Evaluation

Journal of Orthopedic Research and Therapy · 2022

DOI: 10.29011/2575-8241.001255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopedic Research and Therapy, 2022.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The purpose of this study was to compare the clinical and histological effects of Adipose Tissue-Derived Mesenchymal Stem Cells (AD-MSCs) and Platelet-Rich Plasma (PRP) in the arthroscopic treatment of chondral defects of the knee joint.

Methods

This is a randomized controlled trial including 46 patients affected by a knee monocompartmental chondral lesion (Outerbridge grade IV).All patients underwent arthroscopic microfracture and autologous PRP injection and were randomized into 2 groups: in group A they were additionally treated with autologous AD-MSCs injection whilst in group B they didn't receive any additional treatment.Clinical outcomes were assessed with the Oxford Knee Score (OKS), the International Knee Documentation Committee (IKDC) score, and the Visual Analogue Scale (VAS) before the treatment and at 1, 6, 12 and 24 months post-operatively.The histological evaluation was performed on biopsy specimens taken from 6 patients (needing a subsequent high tibial osteotomy and experiencing a second-look arthroscopy.

Results

Based on the results of OKS, IKDC and VAS, a significant clinical improvement was detected in both groups at 6, 12 and 24 months of follow-up, with no significant statistical difference in treatment effect.On the other hand, the histological evaluation of the 6 biopsy specimens confirmed better ultrastructural results in group A, with hyaline-like cartilage closely resembling native tissue.

Zitieren

APA

(2022). Adipose Tissue-Derived Mesenchymal Stem Cells (AD-MSC) Versus Platelet-Rich Plasma (PRP) in the Arthroscopic Treatment of Chondral Defects of The Knee: What’s The Best? A Histological and Clinical Evaluation. Journal of Orthopedic Research and Therapy. https://doi.org/10.29011/2575-8241.001255

Vancouver

Adipose Tissue-Derived Mesenchymal Stem Cells (AD-MSC) Versus Platelet-Rich Plasma (PRP) in the Arthroscopic Treatment of Chondral Defects of The Knee: What’s The Best? A Histological and Clinical Evaluation. Journal of Orthopedic Research and Therapy. 2022. doi:10.29011/2575-8241.001255

BibTeX
@article{euvimed2022,
  title = {Adipose Tissue-Derived Mesenchymal Stem Cells (AD-MSC) Versus Platelet-Rich Plasma (PRP) in the Arthroscopic Treatment of Chondral Defects of The Knee: What’s The Best? A Histological and Clinical Evaluation},
  journal = {Journal of Orthopedic Research and Therapy},
  year = {2022},
  doi = {10.29011/2575-8241.001255}
}
Kostenlos starten →